Antiphospholipid antibody syndrome: An acquired cause of venous and arterial hypercoagulability

Mount Sinai Journal of Medicine

Volumn 64, Issue 6, 1997, Pages 376-382

  Petri, Michelle ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticardiolipin; Antiphospholipid antibody; Hypercoagulability; Lupus anticoagulant

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PREDNISONE; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE CLASSIFICATION; FEMALE; FETUS WASTAGE; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; MALE; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ABORTION, HABITUAL; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERIES; BLOOD COAGULATION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNANCY; VEINS;

EID: 0030714694     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Oosting JD, Derksen RHWM, Bobbink IWG, et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: An explanation for their pathogenic mechanism? Blood 1993; 81:2618-2625.
2. Moore JE, Mohr CF. Biologically false positive serologic tests for syphilis. JAMA 1952; 150:467-473.
3. Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952; 31:621-622.
4. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemostasis 1995; 74:1185-1190.
5. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120-4124.
6. 2-glycoprotein-I in patients with primary antiphospholipid syndrome. J Rheumatol 1995; 22:1894-1898.
7. 2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93:181-186.
8. Asherson RA, Cervera R. Anticardiolipin antibodies, chronic biologic false positive tests for syphilis and other antiphospholipid antibodies. In: Wallace DJ, Hahn BH, editors. Dubois' Lupus Erythematosus. 4th ed. Philadelphia: Lea & Febiger; 1993.
9. Petri M, Golbus M, Anderson R, et al. Antinuclear antibodies, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum 1987; 30:601-606.
10. Hunt JE, McNeil HP, Morgan GJ, et al. A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 1:75-81.
11. Alarcón-Segovia D, Delezé M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: A prospective analysis of 500 consecutive patients. Medicine 1989; 68:353-374.
12. Alarcón-Segovia D, Sánchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16:482-488.
13. Petri M. Epidemiology of the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette J-C, Shoenfeld Y, editors. The antiphospholipid syndrome. CRC Press: Boca Raton; 1996. pp. 13-28.
14. Manoussakis MN, Tzioufas AG, Silis MP, et al. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69:557-565.
15. Hughes GRV. The antiphospholipid syndrome: Ten years on. Lancet 1993; 342:341-344.
16. McNeil HP, Hunt JE, Krilis SA. Antiphospholipid antibodies: New insights into their specificity and clinical importance. Scand J Immunol 1992; 36:647-652.
17. Bick RL, Jakway J, Baker Jr. WF. Deep vein thrombosis: prevalence of etiologic factors and results of management in 100 consecutive patients. Semin Thromb Hemostasis 1992; 18:267-274.
18. Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40:1190-1196.
19. Alegre VA, Winkelman RK. Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anti-coagulant. J Am Acad Dermatol 1988; 19:117-124.
20. Carreras LO, Vermylen J, Spitz B, van Assche A. "Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynecol 1981; 88:890-894.
21. Martinuzzo ME, Maclouf J, Carreras LO, Lévy Toledano S. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thromb Haemost 1993; 70:667-671.
22. Goldschmidt-Clermont PJ, Shear WS, Schwartzberg J, et al. Clues to the death of an Olympic champion. Lancet 1996; 347:1833.
23. Asherson RA, Derksen RHWM, Harris EN, et al. Chorea in systemic lupus erythematosus and "Lupus-Like" disease: Association with antiphospholipid antibodies. Semin Arthritis Rheum 1987; 16:253-259.
24. Chang R, Quismorio Jr. P. Transverse myelopathy in systemic lupus erythematosus (SLE) [abstract]. Arthritis Rheum 1990; 33:S102.
25. Vaarala O, Alfthan G, Jauhiainen M, et al. Cross reaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993; 341:923-925.
26. 2-glycoprotein I antibodies [Abstract]. Lupus 1996; 5:517.
27. Grob JJ, Bonerandi JJ. Cutaneous manifestations associated with the presence of the lupus anticoagulant. J Am Acad Dermatol 1986; 15:211-219.
28. Ginsburg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992; 117:997-1002.
29. Petri M. Thrombosis and systemic lupus erythematosus: The Hopkins Lupus Cohort perspective. Scand J Rheumatol 1996; 25:191-193.
30. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995; 332:993-997.
31. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117:303-308.
32. Derksen RHWM, de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993; 52:689-692.
33. McCrae KR. Antiphospholipid antibody associated thrombosis: A consensus for treatment? Lupus 1996; 5:560-570.
34. Cowchock FS, Reece EA, Balaban D, et al. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166:1318-1323.